Ramsay Santé FY2026 Revenue Rises 3.3% to €5.4bn as EBITDA Hits €638m

Ramsay Santé··FRSEAU·Read original
3▲1 ▼0Impact / 5
Summary · why it matters

Ramsay Santé reported group revenue of €5,381.1m for the year ended 30 June 2026, up 3.3% on a reported basis and 2.3% like-for-like, with EBITDA rising 2.6% to €637.7m at an 11.9% margin. The group's net loss attributable to owners narrowed to €48.3m from €54.1m a year earlier, while net cash flow from operating activities fell €169m to €524.7m as working capital normalized, and net financial debt stood at €3,584.9m, including €1,638.7m of restated pre-IFRS16 net debt, leaving restated net leverage stable at 4.7x. Ramsay Santé said it will not propose a dividend for the year ending 30 June 2026, in line with recent years. Chief Executive Officer Pascal Roché credited the results to an integrated care offering and operational discipline, and the group used its 17 September Capital Markets Day to unveil a new strategic roadmap, Connecting Care 2030, targeting revenue growth of about 3.0% per annum and a gradually improving EBITDA margin through FY2029, alongside continued deleveraging toward pre-IFRS net debt to EBITDA below 4.0x. In Sweden, Capio began a new contract for St. Göran Hospital on 5 January 2026, awarded for at least eight years with an option to extend up to four more, worth an estimated €4.8bn over 12 years. Ramsay Santé also closed a €1.75bn senior debt refinancing on 22 July 2026, comprising a €1.55bn Term Loan B and a €200m revolving credit facility, extending senior debt maturities from 2031 to 2033, and has applied for a foreign exempt listing on the ASX through CDIs as shareholder Ramsay Health Care Limited proposes to distribute its 52.79% stake to its own shareholders.

Impact on assets 2

Aging Population▲ · 1 stocks
Ramsay Generale De Sante
GDS
▲ PositiveCapitalDemandrelevance

FY2026 revenue rose 3.3% to €5.4bn and EBITDA rose 2.6% to €638m, with net loss narrowing to €48.3m.

Biotech & Genomic Medicine▲ · 1 stocks

Off-coverage companies 1

Capio ABPrivate▲ Positive
Demandrelevance

Capio began a new contract for St. Göran Hospital on 5 January 2026, awarded for at least eight years and worth an estimated €4.8bn over 12 years.

© 2026 MarketIVNews